Decision Guide to Help Determine Digital Health Regulatory Pathways
I’ve spent years on the payer side, building GTM strategies and pricing models for digital health products. But here’s the truth: the FDA approval pathway is still murky, even for people who live in this world.
The FDA website has guidance documents—lots of them. But if you’re a founder trying to figure out whether your product needs approval, it’s overwhelming. The guidances are dense, full of nuance, and frankly, hard to parse without a regulatory background.
This matters because getting your regulatory strategy wrong is expensive. I’ve seen startups delay commercial launch by 2+ years or burn millions in unnecessary capital because they didn’t think through the FDA pathway early enough. The question of “Do I need FDA approval?” isn’t just a legal checkbox—it fundamentally shapes your business model, target market, and how you’ll get paid.
So how do you figure this out? I’ve created a decision tree to help you think through it. Quick disclaimer: I’m not a regulatory expert, and this isn’t regulatory advice. But if you need help with your regulatory strategy, reach out—I can connect you with the right regulatory experts.
The Most Important Question in Digital Health
Understanding whether your digital health product requires FDA approval can save you millions of dollars and years of development time. Getting this wrong can mean:
- FDA warning letters and shutdown orders
- Wasted development on products that need approval
- Unnecessary delays pursuing approval you don’t need
- Legal liability and patient safety issues
It’s NOT about how sophisticated your technology is, what disease you address, or whether you use AI.
It’s about WHAT YOUR SOFTWARE DOES and WHAT CLAIMS YOU MAKE.
Follow this decision tree step by step. Answer each question honestly based on what your product actually does (not what you wish it could do).
• Electronic health records (EHR)
• Appointment scheduling
• Insurance claims/billing
• Telemedicine platforms (video calls)
• Patient portals
• Hospital bed management
⚠️ If it ONLY does these → NO FDA APPROVAL NEEDED
If it does these PLUS medical functions → Continue to Question 3
• Fitness tracking (steps, calories)
• Meditation apps
• Nutrition logging
• Sleep tracking (not diagnosing disorders)
• Lifestyle coaching
✓ RESULT: NO FDA APPROVAL NEEDED
• Diagnose, treat, cure, prevent disease
• Manage disease symptoms
• Replace/augment clinical decisions
• Analyze medical data for clinical insights
⚠️ The PROVIDER makes all medical decisions, not the software
📊 Outcome Summary
→ Is general wellness/fitness without disease claims
→ Provides health information/education only
→ Connects patients to providers (telemedicine)
→ Displays user-entered data without interpretation
→ Iterate and update freely
→ Make general wellness claims
→ Provide patient-specific clinical recommendations
→ Replace healthcare provider decision-making
→ Treats, manages, or prevents disease
→ Predicts specific disease risk or acute events
→ Analyzes medical device data or images
→ Uses multi-modal medical data for clinical purposes
De Novo: 6-12 months, $500K-$2M
PMA: 1-3 years, $1M-$10M+ (rare for software)
→ Identify predicate device (for 510(k) route)
→ Plan clinical validation studies
→ Budget 6-18 months, $500K-$2M+
📱 Real-World Examples
Why NO FDA: General wellness, no disease claims
Why NO FDA: Communication platform, doctors make decisions
Why YES FDA: Disease management, analyzes device data
Why Significant: Early adopter of PDURS model, positioning software as drug companion
💡 Pro Tips for Digital Health Founders
1. When in doubt, ask FDA: Pre-Submission meetings are free and can save you millions.
2. Your marketing determines regulation: Claims matter more than technology.
3. Document your decision: Write a regulatory strategy memo. Get legal review.
4. Don’t try to outsmart FDA: If you’re providing medical value, embrace regulation.
5. Plan early: Regulatory strategy should be part of product development from day one.
Important Disclaimer:
This decision tree provides general guidance based on FDA regulations as of January 2025. It is NOT legal or regulatory advice. Always consult with qualified regulatory professionals.
Resources: FDA Digital Health Center of Excellence • Clinical Decision Support Guidance (2022) • PDURS Draft Guidance (Sept 2023)

Leave a comment